In a case that could have profound implications for all medical device patents, lawyers representing medical device manufacturer Medela have asked the U.S. Supreme Court to determine whether judges should have the power, rather than juries, to decide whether a patent should be invalidated on the grounds of obviousness.
President-elect Barack Obama’s administration has targeted two federal healthcare agencies, the Centers for Disease Control and Prevention (CDC) and the FDA, for a leadership reshuffling.
|
Clarifying legal rights of patient control over EHRs could be the key to making the best use of the huge amount of electronic medical information that the stimulus funding will create in the next few years, according to a commentary published in the March 25 issue of the Journal of the American Medical Association ( JAMA).
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.